NEULANDLAB.BONEULANDLAB.BOBSE

Revenue (LTM)

$14.8B

-5.2% YoY

Net Income (LTM)

$2.6B

-13.3% YoY

Free Cash Flow

$1.1B

Revenue CAGR (5Y)

+14.1%

Marginsimproving

FCF$1.1B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	9,243	9,233↓0.1%	11,609↑25.7%	15,586↑34.3%	14,768↓5.2%
Gross Profit	3,635	3,698↑1.8%	5,471↑47.9%	8,248↑50.8%	7,263↓11.9%
Operating Income	1,096	961↓12.4%	2,343↑143.9%	5,318↑126.9%	2,577↓51.5%
Net Income	806	638↓20.8%	1,635↑156.2%	3,001↑83.5%	2,601↓13.3%
EBITDA	1,629	1,404↓13.8%	2,792↑98.8%	4,748↑70.1%	4,202↓11.5%
EPS Diluted	62.85	49.74↓20.9%	127.45↑156.2%	233.89↑83.5%	202.74↓13.3%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	24	51↑109.0%	454↑792.0%	876↑92.8%	1,319↑50.6%
Total Current Assets	5,496	5,808↑5.7%	7,609↑31.0%	9,211↑21.1%	11,395↑23.7%
Total Assets	13,248	13,835↑4.4%	15,798↑14.2%	18,326↑16.0%	21,799↑19.0%
Total Current Liabilities	3,685	3,632↓1.5%	4,390↑20.9%	4,277↓2.6%	4,657↑8.9%
Total Liabilities	5,383	5,430↑0.9%	5,857↑7.9%	5,499↓6.1%	6,551↑19.1%
Total Equity	7,865	8,405↑6.9%	9,941↑18.3%	12,827↑29.0%	15,248↑18.9%
Total Debt	1,823	2,405↑31.9%	1,284↓46.6%	954↓25.7%	1,571↑64.7%
Net Debt	1,799	2,354↑30.9%	830↓64.7%	78↓90.6%	252↑222.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	1,894	604↓68.1%	2,372↑292.8%	2,612↑10.1%	3,174↑21.5%
Capital Expenditure	-1,054	-977↑7.3%	-661↑32.3%	-1,437↓117.3%	-2,065↓43.7%
Free Cash Flow	840	-373↓144.4%	1,711↑558.7%	1,175↓31.3%	1,109↓5.6%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	-88	27↑130.3%	403↑1418.4%	422↑4.6%	444↑5.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance